Literature DB >> 9603110

The role of leukotriene modifiers in the treatment of asthma.

R J Horwitz1, K A McGill, W W Busse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603110     DOI: 10.1164/ajrccm.157.5.9706059

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  14 in total

1.  Sahaja yoga in the management of moderate to severe asthma: a randomised controlled trial.

Authors:  R Manocha; G B Marks; P Kenchington; D Peters; C M Salome
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

Review 2.  Difficult asthma: beyond the guidelines.

Authors:  I Balfour-Lynn
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

3.  The anti-apoptotic effect of leukotriene D4 involves the prevention of caspase 8 activation and Bid cleavage.

Authors:  Katarina Wikström; Maria Juhas; Anita Sjölander
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 4.  Antileukotriene drugs in childhood asthma: what is their place in therapy?

Authors:  H Selvadurai; C Mellis
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

5.  Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans.

Authors:  Kyoung-Ah Kim; Pil-Whan Park; Kyong Rae Kim; Ji-Young Park
Journal:  Br J Clin Pharmacol       Date:  2006-09-19       Impact factor: 4.335

Review 6.  Recent changes: pulmonary medicine.

Authors:  N Roche
Journal:  BMJ       Date:  1999-01-16

7.  Prevalence of asthma and its association with glycemic control among youth with diabetes.

Authors:  Mary Helen Black; Andrea Anderson; Ronny A Bell; Dana Dabelea; Catherine Pihoker; Sharon Saydah; Michael Seid; Debra A Standiford; Beth Waitzfelder; Santica M Marcovina; Jean M Lawrence
Journal:  Pediatrics       Date:  2011-09-26       Impact factor: 7.124

8.  Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response.

Authors:  Z Z Shi; B Han; G M Habib; M M Matzuk; M W Lieberman
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 9.  Pranlukast: a review of its use in the management of asthma.

Authors:  Susan J Keam; Katherine A Lyseng-Williamson; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma.

Authors:  Chang Cai; Jiong Yang; Suping Hu; Meiqian Zhou; Wei Guo
Journal:  Lung       Date:  2007-03-28       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.